Search

for
Search:

Did you mean Pegylated Interferon?

GlossaryPegylated Interferon

modified interferon with polyethylene glycol for prolonged therapeutic effect

Pegylated Interferon, often abbreviated as PEG-IFN, is a modified form of interferon used to treat certain viral infections and cancers. The "pegylation" process involves attaching polyethylene glycol (PEG) molecules to the interferon, which helps to prolong its presence in the bloodstream, reduce the frequency of dosing, and minimize side effects. This modification enhances the therapeutic efficacy and patient compliance compared to standard interferon treatments.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 225 results

research Alopecia Areata During Pegylated Interferon Alpha2a Treatment in Chronic Hepatitis B Patients

January 2014 in “대한피부과학회지”

A hepatitis B patient lost hair in patches after starting and stopping a treatment with pegylated interferon alpha2a.

research Pegylated-Interferon-Alpha 2a in Clinical Practice: How to Manage Patients Suffering from Side Effects

17 citations, February 2011 in “Expert Opinion on Drug Safety”

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

Lichen Planus and Other Cutaneous Manifestations in Chronic Hepatitis C: Pre- and Post-Interferon-Based Treatment Prevalence in a Cohort from a Low Hepatitis C Virus Endemic Area

research Lichen Planus and Other Cutaneous Manifestations in Chronic Hepatitis C: Pre- and Post-Interferon-Based Treatment Prevalence in a Cohort from a Low Hepatitis C Virus Endemic Area

34 citations, April 2008 in “Journal of the European Academy of Dermatology and Venereology”

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

Exacerbation of Alopecia Areata During Pegylated Interferon Alpha-2b and Ribavirin Therapy, Possibly Due to the Collapse of Hair Follicle Immune Privilege

research Exacerbation of Alopecia Areata During Pegylated Interferon Alpha-2b and Ribavirin Therapy, Possibly Due to the Collapse of Hair Follicle Immune Privilege

10 citations, September 2014 in “European Journal of Dermatology”

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

research Widespread and Eruptive Comedonal Lesions With Alopecia

November 2022 in “JAAD case reports”

A man with skin and hair symptoms improved partially with specific treatment.

View more "pegylated interferon alpha2a" in research →

Community Join

0 / 0 results

— no results